For the year ending 2025-12-31, AXSM has $689,805K in assets. $601,510K in debts. $322,933K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 322,933 | |||
| Accounts receivable, net | 224,464 | |||
| Inventories, net | 27,938 | |||
| Prepaid and other current assets | 13,651 | |||
| Total current assets | 588,986 | |||
| Equipment, net | 562 | |||
| Right-of-use asset | 20,858 | |||
| Goodwill | 12,042 | |||
| Intangible asset, net | 40,519 | |||
| Non-current inventory and other assets | 26,838 | |||
| Total assets | 689,805 | |||
| Accounts payable | 65,537 | |||
| Accrued expenses and other current liabilities | 232,853 | |||
| Operating lease liability, current portion | 434 | |||
| Contingent consideration, current | 10,012 | |||
| Short-term borrowings | 70,000 | |||
| Total current liabilities | 378,836 | |||
| Contingent consideration, non-current | 77,540 | |||
| Loan payable, long-term | 117,746 | |||
| Operating lease liability, long-term | 23,182 | |||
| Finance lease liability, long-term | 4,206 | |||
| Total liabilities | 601,510 | |||
| Common stock, 0.0001 par value per share (150,000,000 shares authorized, 50,882,766 and 48,667,587 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively) | 5 | |||
| Additional paid-in capital | 1,394,251 | |||
| Accumulated deficit | -1,305,961 | |||
| Total stockholders equity | 88,295 | |||
| Total liabilities and stockholders equity | 689,805 | |||
Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM)